CGS 3.55% $1.36 cogstate ltd

Ann: Industry News, page-4

  1. 51 Posts.
    lightbulb Created with Sketch. 1
    Does this mean that COgstate didn't take part in this phase 3 Clarity AD study of Lecanemab?
    "Cogstate was not party to the collaborative arrangement between Eisai and Biogen in respect of the confirmatory clinical study"
    So if not Cogstate, who then?
 
watchlist Created with Sketch. Add CGS (ASX) to my watchlist
(20min delay)
Last
$1.36
Change
-0.050(3.55%)
Mkt cap ! $233.1M
Open High Low Value Volume
$1.40 $1.41 $1.36 $67.57K 48.27K

Buyers (Bids)

No. Vol. Price($)
1 3999 $1.36
 

Sellers (Offers)

Price($) Vol. No.
$1.43 5121 1
View Market Depth
Last trade - 16.10pm 09/05/2024 (20 minute delay) ?
Last
$1.40
  Change
-0.050 ( 1.39 %)
Open High Low Volume
$1.40 $1.41 $1.39 6160
Last updated 15.59pm 09/05/2024 ?
CGS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.